0       0

Expert Perspectives in Advanced Prostate Cancer


HiddenEval001 - Expert Perspectives in Advanced Prostate Cancer


Description

Objectives:

  • Compare the benefits and risks associated with new systemic agents for the treatment of castrate resistant prostate cancer (CRPC) including immunotherapy, secondary hormonal agents, chemotherapy, and radiopharmaceuticals.
  • Assess current treatment guidelines regarding appropriate sequencing of new therapeutic approaches for the treatment of CRPC.
  • Appraise individual patient disease characteristics: recognize, understand, and manage disease and treatment related complications associated with CRPC.
  • Formulate appropriate care plans and provide counsel for patients and their families.

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content
token-speaker-name image
token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content